Armistice Capital »

Treace Med Concepts shares owned by Armistice Capital

Quarter-by-quarter ownership of Treace Med Concepts (TMCI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Treace Med Concepts

Tip: Access up to 7 years of quarterly data

All positions including Treace Med Concepts held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Treace Med Concepts by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $31M 2.4M 13.05

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Treace Med Concepts

Vanguard Group
BlackRock
Morgan Stanley
Armistice Capital
William Blair Investment Management
Perceptive Advisors
Millennium Management
Atlantic Trust
Emerald Advisers
TimesSquare Capital Management
Soleus Capital Management
Deutsche Bank Aktiengesellschaft
Emerald Mutual Fund Advisers, Trust
Geode Capital Management
Kornitzer Capital Management

View all funds holding Treace Med Concepts